HLA-DR3 and HLA-DR5 associated thyrotoxicosis--two different types of toxic diffuse goiter. 1983

H Schleusener, and G Schernthaner, and W R Mayr, and P Kotulla, and U Bogner, and R Finke, and H Meinhold, and K Koppenhagen, and K W Wenzel

One hundred fifty patients with toxic and scintigraphically diffuse goiter were HLA typed (A, B, C, DR). One group consisted of 101 patients with concomitant Graves' ophthalmopathy and/or TSH-binding inhibiting antibodies (TBIAb). Forty nine patients had neither ophthalmopathy nor TBIAb. The former group showed a higher prevalence of HLA-B8 and DR3 compared to a normal control group. The latter group showed a higher frequency of HLA-DR5, whereas the HLA-B8 and DR3 antigens were slightly below normal prevalence. These data indicate an immunogenetic heterogeneity in patients with toxic diffuse goiter. A group of 47 hyperthyroid patients with single autonomous thyroid adenoma had no increased prevalence of any HLA-antigens. Patients with long term remission did not show an altered prevalence of any of the HLA antigens compared to controls. In contrast, patients with Graves' ophthalmopathy and/or TBIAb activity who relapsed had a significantly higher prevalence of HLA-B8 DR3, whereas patients without TBIAb and eye signs who relapsed had a significantly higher prevalence of HLA-DR5 than the control group.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D006111 Graves Disease A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy). Basedow's Disease,Exophthalmic Goiter,Goiter, Exophthalmic,Graves' Disease,Basedow Disease,Hyperthyroidism, Autoimmune,Basedows Disease,Disease, Basedow,Disease, Basedow's,Disease, Graves,Disease, Graves',Exophthalmic Goiters,Goiters, Exophthalmic
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000949 Histocompatibility Antigens Class II Large, transmembrane, non-covalently linked glycoproteins (alpha and beta). Both chains can be polymorphic although there is more structural variation in the beta chains. The class II antigens in humans are called HLA-D ANTIGENS and are coded by a gene on chromosome 6. In mice, two genes named IA and IE on chromosome 17 code for the H-2 antigens. The antigens are found on B-lymphocytes, macrophages, epidermal cells, and sperm and are thought to mediate the competence of and cellular cooperation in the immune response. The term IA antigens used to refer only to the proteins encoded by the IA genes in the mouse, but is now used as a generic term for any class II histocompatibility antigen. Antigens, Immune Response,Class II Antigens,Class II Histocompatibility Antigen,Class II Major Histocompatibility Antigen,Ia Antigens,Ia-Like Antigen,Ia-Like Antigens,Immune Response Antigens,Immune-Associated Antigens,Immune-Response-Associated Antigens,MHC Class II Molecule,MHC II Peptide,Class II Antigen,Class II Histocompatibility Antigens,Class II MHC Proteins,Class II Major Histocompatibility Antigens,Class II Major Histocompatibility Molecules,I-A Antigen,I-A-Antigen,IA Antigen,MHC Class II Molecules,MHC II Peptides,MHC-II Molecules,Antigen, Class II,Antigen, I-A,Antigen, IA,Antigen, Ia-Like,Antigens, Class II,Antigens, Ia,Antigens, Ia-Like,Antigens, Immune-Associated,Antigens, Immune-Response-Associated,I A Antigen,II Peptide, MHC,Ia Like Antigen,Ia Like Antigens,Immune Associated Antigens,Immune Response Associated Antigens,MHC II Molecules,Molecules, MHC-II,Peptide, MHC II,Peptides, MHC II
D015795 HLA-B8 Antigen A specific HLA-B surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-B*08 allele family. HLA Class I Histocompatibility Antigen, B-8 alpha Chain,HLA-B8,Antigen, HLA-B8,HLA B8 Antigen,HLA Class I Histocompatibility Antigen, B 8 alpha Chain
D015803 HLA-DR3 Antigen An HLA-DR antigen which is associated with HLA-DRB1 CHAINS encoded by DRB1*03 alleles. HLA-DR3,Antigen, HLA-DR3,HLA DR3 Antigen
D015805 HLA-DR5 Antigen A broad-specificity HLA-DR antigen that is associated with HLA-DRB1 CHAINS encoded by DRB1*11 and DRB1*12 alleles. HLA-DR5,Antigen, HLA-DR5,HLA DR5 Antigen
D018828 Immunoglobulins, Thyroid-Stimulating Autoantibodies that bind to the thyroid-stimulating hormone (TSH) receptor (RECEPTORS, THYROTROPIN) on thyroid epithelial cells. The autoantibodies mimic TSH causing an unregulated production of thyroid hormones characteristic of GRAVES DISEASE. Antibodies, Thyroid-Stimulating,Ig Thyroid Stimulating,Thyroid-Stimulating Antibodies,Thyroid-Stimulating Autoantibodies,Thyroid-Stimulating Autoantibody,Thyroid-Stimulating Immunoglobulins,Immunoglobulin, Thyroid-Stimulating,Thyroid Stimulating Antibody,Thyroid-Stimulating Immunoglobulin,Antibody, Thyroid Stimulating,Autoantibody, Thyroid-Stimulating,Immunoglobulin, Thyroid Stimulating,Stimulating Antibody, Thyroid,Thyroid Stimulating Antibodies,Thyroid Stimulating Autoantibodies,Thyroid Stimulating Autoantibody,Thyroid Stimulating Immunoglobulin,Thyroid Stimulating Immunoglobulins,Thyroid Stimulating, Ig

Related Publications

H Schleusener, and G Schernthaner, and W R Mayr, and P Kotulla, and U Bogner, and R Finke, and H Meinhold, and K Koppenhagen, and K W Wenzel
March 1970, Fel'dsher i akusherka,
H Schleusener, and G Schernthaner, and W R Mayr, and P Kotulla, and U Bogner, and R Finke, and H Meinhold, and K Koppenhagen, and K W Wenzel
January 1991, Problemy endokrinologii,
H Schleusener, and G Schernthaner, and W R Mayr, and P Kotulla, and U Bogner, and R Finke, and H Meinhold, and K Koppenhagen, and K W Wenzel
October 1990, Klinicheskaia meditsina,
H Schleusener, and G Schernthaner, and W R Mayr, and P Kotulla, and U Bogner, and R Finke, and H Meinhold, and K Koppenhagen, and K W Wenzel
January 1981, Problemy endokrinologii,
H Schleusener, and G Schernthaner, and W R Mayr, and P Kotulla, and U Bogner, and R Finke, and H Meinhold, and K Koppenhagen, and K W Wenzel
January 1990, Problemy endokrinologii,
H Schleusener, and G Schernthaner, and W R Mayr, and P Kotulla, and U Bogner, and R Finke, and H Meinhold, and K Koppenhagen, and K W Wenzel
January 1978, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
H Schleusener, and G Schernthaner, and W R Mayr, and P Kotulla, and U Bogner, and R Finke, and H Meinhold, and K Koppenhagen, and K W Wenzel
April 1975, Vrachebnoe delo,
H Schleusener, and G Schernthaner, and W R Mayr, and P Kotulla, and U Bogner, and R Finke, and H Meinhold, and K Koppenhagen, and K W Wenzel
January 1994, Terapevticheskii arkhiv,
H Schleusener, and G Schernthaner, and W R Mayr, and P Kotulla, and U Bogner, and R Finke, and H Meinhold, and K Koppenhagen, and K W Wenzel
December 1968, Akusherstvo i ginekologiia,
H Schleusener, and G Schernthaner, and W R Mayr, and P Kotulla, and U Bogner, and R Finke, and H Meinhold, and K Koppenhagen, and K W Wenzel
January 1993, Terapevticheskii arkhiv,
Copied contents to your clipboard!